14.68
+7.23%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About InfuSystem Holdings
From its filings with the US Securities and Exchange Commission
InfuSystem Holdings is based in Rochester Hills, Michigan and is incorporated in Delaware. Its shares trade on NYSE under the ticker INFU. The SEC classifies its business as surgical & medical instruments & apparatus. In the fiscal year to 31 December 2025, it reported revenue of $143.4m and net income of $6.6m. At that date it held total assets of $100.6m and shareholders' equity of $57.3m.
InfuSystem Holdings, Inc. ("we," "us," "our" or the "Company") is a Delaware corporation. Formed in 2005, the Company operates through its subsidiary InfuSystem, Inc., a Delaware corporation ("InfuSystem" or "ISI").
We are a leading national healthcare service provider, facilitating outpatient care for Durable Medical Equipment (DME) manufacturers and healthcare providers. We provide our products and services to hospitals, oncology practices, ambulatory surgery centers, and other alternate site healthcare providers. Our headquarters is in Rochester Hills, Michigan, and we operate our business from a total of seven locations in the United States ("U.S.") and Canada.
We provide our services under a two-platform model: Patient Services and Device Solutions.
Our lead platform, Patient Services, provides last-mile solutions for clinic-to-home healthcare where the continuing treatment involves complex DME and related services.
The Device Solutions platform compliments our Patient Services platform to enhance growth in existing markets. Device Solutions is strategically oriented with the Company's existing relationships with healthcare providers to incrementally capitalize on opportunities related to other services their practices offer or may plan to offer in the future.
Quoted from its 10-K, filed 27 Feb 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Listed since
- 15 Jun 2006
- Employees
- 461
- Website
- ir.infusystem.com ↗
- Head office
- 3851 WEST HAMLIN ROAD, ROCHESTER HILLS, MI, 48309
- Incorporated in
- DE
- Classification
- Surgical & Medical Instruments & Apparatus
- Filer status
- Accelerated filer<br>Smaller reporting company
Leadership
Pay as last reported
- Mr. Ronald HundzinskiIndependent Chairman of the Board$63,702
- Ms. Carrie LachancePresident, Chief Executive Officer, Director, since 2019$1.3m
- Mr. Barry SteeleChief Financial Officer, Executive Vice President$1.3m
- Mr. Jerod FunkeChief Human Resources Officer, Executive Vice President
- Mr. Addam ChupaExecutive Vice President, Chief Information Officer
- Mr. Scott ShudaDirector$195,716
- Mr. Kenneth EichenbaumIndependent Director$138,197
- Mr. Paul GendronIndependent Director$175,352
- Ms. Beverly HussIndependent Director$141,334
- Mr. Joe DorameInvestor Relations, since 2015
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 50
- Environment
- 54
- Social
- 59
- Governance
- 37
- Carbon reduction policy
- No
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- InfuSystem Holdings Inc has a strong market presence and brand recognition in the healthcare industry, leading to a loyal customer base.
- The company has a wide range of high-quality and technologically advanced infusion pumps, ensuring a competitive advantage over rivals.
- InfuSystem has established strategic partnerships with major healthcare providers, enabling them to secure long-term contracts and stable revenue streams.
Weaknesses
- The company heavily relies on third-party suppliers for the production and maintenance of their infusion pumps, leading to potential supply chain disruptions and increased costs.
- InfuSystem faces regulatory and compliance challenges in the highly regulated healthcare industry, which may result in increased expenses and legal risks.
- The company lacks diversification in its product portfolio, primarily focusing on infusion pumps, which makes them vulnerable to market fluctuations and shifts in customer demand.
Opportunities
- The growing demand for home healthcare services presents an opportunity for InfuSystem to expand its customer base and revenue by providing infusion pump solutions for at-home treatments.
- The increasing prevalence of chronic diseases, such as cancer and diabetes, creates a larger market for infusion pumps, allowing InfuSystem to tap into new patient segments.
- InfuSystem can explore international markets and strategic partnerships to expand its global presence and increase market share.
Threats
- Intense competition within the healthcare industry poses a threat to InfuSystem's market share and profitability.
- Changes in healthcare reform and policies may impact reimbursement rates for InfuSystem's products and services, potentially reducing their revenue.
- The ongoing COVID-19 pandemic presents challenges in terms of disrupted supply chains, reduced healthcare facility operations, and financial uncertainties.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.